Announcements Jennifer Baumgartner, Ph.D. July 7, 2023 Student loan debtis a commonbarrierfor health professionals starting and sustaining a biomedical or biobehavioral research career.TheNational Institutes of Health (NIH)Loan Repayment Programs (LRPs) are a set of programs established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers.These programs may repayup to $100,000 of qualified student loan debt for a 2-year awardto those committed to a career in biomedical research. The goal of these incredible and potentially life-changing programs is to recruit and retain highly qualified health professionals in research careers by lessening the burden of student loans. | We encourage all early-stage investigators to submit an abstract for a flash talk and/or poster presentation through ourabstract submission form. Graduate students, postdocs, and junior investigators (up to assistant professors) are eligible. Applicants must commit to attend the meetingin person in Bethesda, Maryland. Limited travel awards will be available to support selected presenters. The deadline for submission has been extended to Sunday, July 23, 2023.We will notify applicants of the status of their submissions byAugust 11, 2023. Resources for Researchers Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp) PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) Single Source : NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed) Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Diversity Resources ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)- NCCIH is participating in a new NOFO soliciting T32 applications to train predoctoral scholars from diverse backgrounds, including those from groups underrepresented in prevention relevant fields, in three integrated areas: (1) health disparities/health equity research, (2) development and implementation of multi-level preventive interventions, and (3) methods for the design and analysis of studies to evaluate multi-level preventive interventions (see Notice of NIH's Interest in Diversity). NCCIH is particularly interested in applications proposing training programs on these topics that include research on complementary and integrative approaches and a whole person health perspective (see NCCIH Strategic Priorities). Applications are due October 31, 2023. Contact Dr. Lanay Mudd to discuss your application. Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-MH-23-330 and RFA-MH-23-331 K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity
Upcoming Events July 25, 2023- 10:00 a.m. ETto July 26, 2023 5:00 p.m. ET The purpose of this Helping to End Addiction Long-termInitiative, or NIH HEAL Initiative, workshop is to examinethe current literature on joint pain research and identify critical knowledge gaps to gain a comprehensive understanding of the whole joint, including the contributions of various articular and periarticular tissue pathologies that lead to pain in different types of joints. In addition, the workshop will explore manipulations and interventions that may help to restore whole joint health.Of particular interest, workshop participants will examine therelationships and interactions amongthe differenttissuecomponents of joints, including myofascial tissues, and their contributionstoand impact onreducing pain by preserving and restoring joint health and function. Five scientific sessions and a final discussion session will cover structural changes in joints, mechanisms of whole joint pathology, differences among joint types and joint pain populations, interventions to address joint pain and disease, and emerging technologies that can be leveraged to advance scientific understanding of joints as complex organs. The intended audience is interested scientists, clinicians, as well as patients, advocates, and other interested stakeholders. Registration is required. | August 9, 2023, 1:00-2:00 p.m. ET; Virtual The National Institutes of Health (NIH) invites you to join a technical assistance webinar to learn more about RFA-AT-24-003 -"HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)"(REISSUE). This webinar is provided for potential applicants who want to learn details about this exciting and unique notice of funding opportunity focusing on myofascial tissues for clinical pain management. Highlights of this webinar include an overview of the scope and impact of this initiative from NCCIH Director, Dr. Helene M. Langevin, as well as application considerations and review requirements from NCCIH program and review staff. A portion of the webinar is entirely devoted to answering applicant questions. Register now. August 16, 2023, 11:00 a.m.-12:15 p.m. ET; Virtual The National Institutes of Health (NIH) is hosting ateaming/collaboration webinarto provide an interactive, teambuilding experience for individuals who are interested in applying forRFA-AT-24-003 HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)(REISSUE). Register now.
|